2010 AnnuAl REpoRT - Ciberdem

Dev Biol, 346, 346-355 (2010)
IF: 4.379 first decile. With other international groups
Nitric oxide repression of Nanog promotes mouse
embryonic stem cell differentiation
Mora-Castilla S, Tejedo JR, Hmadcha A, Cahuana GM,
Martín F, Soria B, Bedoya FJ
Cell Death Differ, 17, 1025-1033 (2010)
IF: 8.240 first quartile
Pancreatic islet cells: a model for calcium-dependent
peptide release
Soria B, Tuduri E, Gonzalez A, Hmadcha A, Martin F, Nadal
A, Quesada I
HFSP Journal, 4, 52-60 (2010)
IF: 1.600 first quartile. With other CIBERDEM groups: A Nadal
Research grants
National projects
TERCEL Network
Instituto de Salud Carlos III, RD06/0010/0025: 2010-2011
Principal Investigator: Bernat Soria
Associate investigators: Franz Martín, Karim Hmdcha,
Francisco Bedoya, Juan Tejedo
Molecular characterization of protective action of NO on
the pancreatic beta-cell
Ministerio de Ciencia e Innovación, SAF-2007-602105:
2007-2010
Principal Investigator: Francisco J Bedoya
Associate investigators: Gladys M Cahuana, Juan R Tejedo
The role of GATA4 transcription factor in endoderm and
pancreas development
Instituto de Salud Carlos III, PI108/0018: 2009-2011
Principal Investigator: Anabel Rojas
Diabetes mellitus cell therapy: the role of intercellular
signalling pathways and intracellular material transfer
Instituto de Salud Carlos III, PI-10/00964: 2010-2013
Principal Investigator: Bernat Soria
Associate investigators: Franz Martín, Karim Hmadcha,
Miguel Martín, Lourdes Acosta, Ana Serna, Alfredo
Santana, Rafael Ruiz, Antonio de la Cuesta, Inmaculada
Pérez Camacho, Yolanda Aguilera, Mónica Navarro
Cell therapy for critical lower-limb ischemia in type
2 diabetes insulinized patients: a study of insulin
demand
MSPS/Dirección General de terapias Avanzadas, TRA-120:
2010-2012
Principal Investigator: Bernat Soria
Associate investigators: Karim Hmadcha, Rafael Ruiz,
Antonio de la Cuesta, Inmaculada Pérez Camacho,
Franz Martín
Autonomous Community projects
The role of endothelial factors in the obtention of insulinsecreting
cells from adult pancreatic stem cells
Consejería de Salud, Junta de Andalucía, PI00022/2008:
2009-2012
Principal Investigator: Franz Martín
Associate investigators: Patricia Moreno, Elvira León,
Verónica Rivero, Javier Navarro
NO regulation of mouse and human beta-cell and
pancreatic islet survival during the isolation process
Consejería de Salud, Junta de Andalucía, PI0095/07:
2008-2011
Principal Investigator: Juan R Tejedo
Associate investigators: Francisco J Bedoya, Gladys M Cahuana
Transcriptional control during endoderm pancreas development
Consejería de Salud, Junta de Andalucía, PI0008/10:
2010-2012
Principal Investigator: Anabel Rojas
Associate investigators: Raquel Araujo
Monoclonal antibody characterization
Fundación Progreso y Salud: 2010-2011
Principal Investigator: Franz Martín
Associate investigators: Genoveva Berná, Gladys M Cahuana
Scientific collaborations within CIBERDEM
The production of monoclonal antibodies which selectively
react with cell surface molecules on human pancreatic
beta cells
ANTIBECELL: 2009-2010
Coordinator: Juan Tejedo
CIBERDEM groups: F Martín, E Montanya, A Nadal
Clinical trials
Intraarterial infusion of autologous mesenchymal stem cells
from adipose tissue in diabetic patients with chronic critical
limb ischemia. Phases I and II
IATA (Iniciativa Andaluza de Terapias Avanzadas),
(CeTMAd/ICPD2008), ClinicalTrials.gov NCT01079403:
2010-2011
Name of the participants: Ruiz R, De la Cuesta A, Soria B,
Hmadcha K
Cellular therapy for type 2 diabetic patients with CLI: Study
of Insulin needs. Phases I and II
IATA (Iniciativa Andaluza de Terapias Avanzadas),
(CeTMOTa/ICPDI/2010) CT 2010-019774-33: 2010-2011
Name of the participants: Ruiz R, De la Cuesta A, Soria B,
Hmadcha K
Multicenter clinical trial for the evaluation of intraarterial
infusion of autologous marrow derived mononuclear cells
116 CibeRdem